Predictors of Survival for Docetaxel as a Subsequent Line after Progression to Platinum-Based Chemotherapy and Immunotherapy

被引：0
|
作者：
Garitaonaindia Diaz, Y. [1 ]
Calvo de Juan, V. [1 ]
Uribarren, M. [1 ]
Redondo Canovas del Castillo, I. [1 ]
Collazo Lorduy, A. [1 ]
Ospina, A. V. [1 ]
Blanco Clemente, M. [1 ]
Lozano, C. [1 ]
Manso, M. [1 ]
Martinez Cutillas, M. [1 ]
Traseira, C. [1 ]
Sanchez Gonzalez, J. C. [1 ]
Nunez Garcia, B. [1 ]
Provencio, M. [1 ]
机构：
[1] Puerta Hierro Univ Hosp, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Docetaxel; NSCLC; Metastatic;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP10.01-06
引用
收藏
页码：S604 / S604
页数：1
相关论文
共 50 条
  • [1] Docetaxel as a subsequent line after progression to platinum-based chemotherapy and immunotherapy
    Garitaonaindia, Yago
    Calvo, Virginia
    Redondo, Isabel
    Uribarren, Maria
    Ospina Serrano, Aylen Vanessa
    Collazo, Ana
    Blanco, Mariola
    Lozano, Carla
    Cutillas, Marta Martinez
    Manso, Marta
    Traseira, Cristina
    Aguado, Ramon
    Matilde Sanchez del Corral, Maria
    Provencio, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] COMPARISON OF DOCETAXEL AND PACLITAXEL FOR ADVANCED ESOPHAGEAL CANCER AFTER PROGRESSION ON PLATINUM-BASED CHEMOTHERAPY
    Ohori, H.
    Takahashi, Y.
    Takahashi, M.
    Gamoh, M.
    ANNALS OF ONCOLOGY, 2013, 24
  • [3] Clinical outcomes with platinum-based chemotherapy after progression on frontline immunotherapy in metastatic urothelial cancer (mUC)
    Szabados, B. E.
    Stockem, C. F.
    Gauna, D. E. Castellano
    Lista, A. Gomez De Liano
    Cardenas, M. Rey
    Valderrama, B. Perez
    Powles, T. B.
    van der Heijden, M. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1346 - S1346
  • [4] Impact of platinum-based chemotherapy on the progression of atherosclerosis
    Sekijima, T.
    Tanabe, A.
    Maruoka, R.
    Fujishiro, N.
    Yu, S.
    Fujiwara, S.
    Yuguchi, H.
    Yamashita, Y.
    Terai, Y.
    Ohmichi, M.
    CLIMACTERIC, 2011, 14 (01) : 31 - 40
  • [5] Avelumab after platinum-based chemotherapy
    Niegisch, G.
    Worst, T. S.
    UROLOGE, 2021, 60 (05): : 640 - 641
  • [6] Gemcitabine and Docetaxel Chemotherapy is a Favorable Treatment as a Second-Line Chemotherapy for Metastatic Urothelial Carcinoma After Failure of a Platinum-Based Regimen
    Naiki, T.
    Kawai, N.
    Okamura, T.
    Ando, R.
    Ikegami, Y.
    Etani, T.
    Tozawa, K.
    Kohri, K.
    UROLOGY, 2012, 80 (03) : S206 - S206
  • [7] Phase 2 Study of Ramucirumab plus Weekly Docetaxel in Stage IV NSCLC Following Progression after Platinum-Based Chemotherapy
    Sebastian, Martin
    Ponce, Santiago
    Nikolinakos, Petros
    Varea, Rocio
    Chao, Bo
    Zimmermann, Annamaria
    Alexandris, Ekaterine
    Lee, Pablo
    Cappuzzo, Frederico
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1079 - S1080
  • [8] Utilities Used in HTAs in mNSCLC Following Progression on or After Platinum-Based Chemotherapy
    Koh, C. Y. C.
    Chavez, G.
    Teague, R.
    Heptinstall, A.
    Adkins, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S737 - S738
  • [9] EFFICACY AND SAFETY OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH POST-OPERATIVE RECURRENCE AFTER PLATINUM-BASED ADJUVANT CHEMOTHERAPY
    Muraki, K.
    Imai, H.
    Shukuya, T.
    Ohhashi, R.
    Koyama, R.
    Mori, T.
    Murakami, H.
    Takahashi, T.
    Yamamoto, N.
    Takahashi, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 148 - 148
  • [10] Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for stage III urothelial cancer
    Einerhand, S.
    Van Dijk, N.
    Van Dorp, J.
    De Feijter, J. M.
    Van Montfoort, M. L.
    Van de Kamp, M. W.
    Boellaard, T. N.
    Hendricksen, K.
    Van der Heijden, M. S.
    Van Rhijn, B. W. G.
    EUROPEAN UROLOGY, 2021, 79 : S1141 - S1142
12345